MYR GMBH has a total of 12 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2015. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are LIGOCYTE PHARMACEUTICALS INC, SCHWEITZER CHEMICAL CORP USA and VIRAX DEV PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | United States | 2 | |
#6 | Japan | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Alexandrov Alexander | 11 |
#2 | Alexander Alexandrov | 1 |
Publication | Filing date | Title |
---|---|---|
EP3392267A1 | Therapy of atherosclerosis, primary biliary cirrhosis and nrlp3 inflammasome-associated disease by htcp inhibitors | |
KR20170066339A | Combination therapy of hbv and hdv infection |